A LinkedIn post from Impilo highlights operational gaps in many heart health virtual care programs, focusing on what it describes as “invisible data” around remote monitoring devices. The post notes that while programs often track whether a patient submitted a reading, fewer have systematic visibility into device arrival, activation status, connectivity issues, or replacement needs.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, this lack of device-to-data transparency can slow patient outreach, hardware replacement, escalation processes, and ultimately clinical outcomes. Impilo points readers to a new blog that reportedly argues device-to-data visibility is a critical layer of infrastructure for scalable heart health virtual care, suggesting that APIs can convert basic dashboards into more robust operational platforms.
The emphasis on building a “single source of truth” for virtual cardiac care data implies that Impilo is positioning its technology as core infrastructure rather than a point solution. For investors, this framing suggests potential for deeper integration into provider workflows and longer-term, infrastructure-like revenue opportunities, particularly as cardiology and digital health programs expand remote monitoring services.
By tying the message to Heart Month, the post appears to align Impilo’s offering with broader public and industry attention on cardiovascular care. If the company can demonstrate that its data and API layer improves program scalability and outcomes, it could strengthen its competitive position in digital health infrastructure and attract interest from health systems, virtual care platforms, and device manufacturers.

